Clinical Trials Logo

Clinical Trial Summary

This is a randomized, placebo controlled, double-blind phase 3 clinical study to evaluate the efficacy and safety of transcranial ultrasound (TUS) using the Sonolysis Headframe as an adjunctive therapy to intravenous (IV) tissue plasminogen activator (tPA) therapy in subjects with acute ischemic stroke that initially present at non-endovascular (EVT) treating hospitals that have established transport services in place to transfer subjects to hospitals capable of performing EVT.

Clinical Trial Description

The primary objective of this study is to assess the safety and efficacy of TUS using the Sonolysis Headframe in combination with systemic tPA (Treatment group) compared to systemic tPA alone (Control group) in subjects with acute ischemic stroke.

Number of Subjects Required:

Lead-in Phase: 40 subjects in the U.S.; Primary Phase: 556 total enrolled subjects (278 per arm)

Number of Study Centers:

Lead-in Phase: Up to 20 Institutions in U.S.; Primary Phase: Up to 70 Institutions worldwide ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03519737
Study type Interventional
Source Cerevast Medical, Inc.
Status Active, not recruiting
Phase N/A
Start date August 17, 2018
Completion date December 31, 2021

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03366818 - New Stent Retriever, VERSI System for AIS N/A
Completed NCT02223273 - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke) N/A
Recruiting NCT02586233 - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke Phase 1/Phase 2
Suspended NCT01694381 - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor N/A
Not yet recruiting NCT01594190 - Physical Activity Immediately After Acute Cerebral Ischemia N/A
Completed NCT01120301 - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Phase 3
Completed NCT00963989 - Imaging Guided Patient Selection for Interventional Revascularization Therapy Phase 4
Completed NCT01021319 - Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI) N/A
Recruiting NCT00710164 - Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke Phase 2/Phase 3
Completed NCT00777140 - Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion Phase 2
Recruiting NCT03669653 - Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke Phase 2/Phase 3
Not yet recruiting NCT03601702 - EmboTrap ® II Revascularization Device (Neuravi) in Acute Ischemic Stroke
Not yet recruiting NCT03608644 - Predictive Factors of Outcome of Mechanical Thrombectomy After Acute Ischemic Stroke
Not yet recruiting NCT03680469 - The Effectiveness of Early Mobilization for Acute Ischemic Stroke Treated With Rt-PA or IA Thrombectomy N/A
Recruiting NCT02964702 - Thrombectomy Revascularization of Intracranial Vessel OcclusioN by Originating From Japan (TRON1-Japan) N/A
Recruiting NCT02133521 - DLBS1033 for Acute Ischemic Stroke Patients Phase 2/Phase 3
Terminated NCT02362984 - DLBS1033 for the Treatment of Acute Ischemic Stroke Phase 3
Completed NCT02297984 - Serum Neuroglobin and HIF-1α in Acute Ischemic Stroke N/A
Completed NCT02415972 - Dynamic Contrast-enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Acute Ischemic Stroke N/A
Recruiting NCT00874601 - Valsartan Efficacy on Modest Blood Pressure Reduction in Acute Ischemic Stroke Phase 4